Page last updated: 2024-10-25

ciprofloxacin and Cockayne-Touraine Disease

ciprofloxacin has been researched along with Cockayne-Touraine Disease in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin-resistant SA was found significantly predominant in chronic wounds (**P < ."1.91Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. ( Acevedo, F; Arancibia, E; Fuentes, I; Morandé, P; Oróstica, K; Palisson, F; Porte, L; Rebolledo-Jaramillo, B; Varela, C; Yubero, MJ, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fuentes, I1
Yubero, MJ1
Morandé, P1
Varela, C1
Oróstica, K1
Acevedo, F1
Rebolledo-Jaramillo, B1
Arancibia, E1
Porte, L1
Palisson, F1

Other Studies

1 other study available for ciprofloxacin and Cockayne-Touraine Disease

ArticleYear
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
    International wound journal, 2023, Volume: 20, Issue:3

    Topics: Ciprofloxacin; Corynebacterium diphtheriae; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica

2023